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Introduction
Cerebrospinal fluid (CSF) examination has produced and keeps producing a large amount of data without substantial standardization of procedures and techniques. The European consensus on the CSF in the diagnosis of multiple sclerosis (MS) [1] did not fully deal with the issue of procedure and method standardization, as a subsequent publication highlighted the need of identifying shared technical and interpretative guidelines [2] .
Since 2000, when the Italian Association of Neuroimmunology (AINI) started promoting and managing the process of standardization of methods and production of guidelines, the judgment on the CSF analysis state of the art moved from Bnearly sufficient,^as reported by a 1995 survey of the Italian Society of Clinical Biochemistry [3] , to Bvery good,^as extrapolated by the data of AINI external quality control schemes between 2000 and 2014. In summary, AINI centers (a) have applied the main methodological and procedural principles of the 1994 consensus [1] ; (b) currently use standardized and certified methods for the determinations of albumin and IgG, which allow the evaluation of blood-CSF barrier damage and intrathecal IgG production, respectively; and (c) exploit the improvements of automation in isoelectric focusing (IEF) techniques, used by a growing number of centers (nothwithstanding that semi-automated instruments for IEF use mini-gels that might perform suboptimally [4] , the AINI controls show that the quality of IEF runs has been improving over years).
The area of CSF biomarkers needs standardization too. For example, in MS, the lack of standardization is one of the main reasons that prevent the entry of new claimed-to-be-effective biomarkers into routine diagnostics. Other reasons include cutoff values for discriminating between patients and controls first optimized and then applied to the same cohorts, thus artificially increasing test sensitivity and specificity, and evaluations of single biomarkers instead of a set of biomarkers, which could allow the real diagnostic power of each of them. Accordingly, a recent and comprehensive review maintains that no new MS biomarker have entered routine diagnostics so far, although the CSF IgM oligoclonal band (OCB) test is the most promising one [5] . Again, the test has never undergone a thorough process of validation and standardization.
Clinical and laboratory aspects
The evaluation of diagnostic performance of CSF tests is complex for the following reasons: lumbar puncture is usually not repeated, CSF volumes obtained are limited, CSF samples from healthy controls are not easily available, and CSF abnormalities are disease-specific in very few cases only. Therefore, in addition to low levels of standardization, sensitivity and specificity of CSF tests often show between-study moderate-high ranges of variation. All these considerations should dictate rational requests for CSF analysis, which should follow thorough evaluations of clinical settings and disease prevalences (Bayes' theorem). The main pathological conditions for which the lumbar puncture is indicated are listed in Table 1 .
Urgent CSF analysis, which includes cell count, glucose, and albumin determination in serum and CSF (CSF total protein as an alternative), is mandatory in suspected infectious meningitis/meningoencephalitis.
Serum and CSF albumin determinations, with calculation of albumin quotient, allow the most accurate measurement of the degree of blood-CSF barrier permeability (Bblood-CSF barrier damage^-which does not correspond to Bbloodbrain barrier damage^), and should replace CSF total proteins in disorders characterized by intrathecal IgG production at least [1] .
IEF full standardization is inherently impossible due to imponderable factors (gel conductivity, electrodes soaking, lot-to-lot differences for ampholytes, electro endosmosis phenomena, environment temperature/degree of humidity). 
Autoimmune encephalitis
Testing for autoantibodies to surface membrane/synaptic neuronal antigens is recommended for the differential diagnosis of encephalitis [6, 7] . Testing CSF samples is mandatory for the detection of anti-N-methyl-D-aspartate receptor (NMDA-R) antibodies, since false negative results have been reported in 14% of the cases testing serum samples only [8] . Preliminary findings suggest that repeated CSF titrations of these antibodies can provide information on prognosis and response to therapy [8] .
Multiple sclerosis and oligoclonal bands
The 1994 consensus report contains seminal and still valid principles for the CSF analysis ( [1] ; BAppendix^). One fundamental recommendation refers to the use of Bimmunofixation after the isoelectric focusing step^for OCB detection. In 2005, the message was reinforced by a joint North AmericanEuropean consensus [9] . A Bfive-pattern scheme^for IEFimmunofixation test interpretation represents another essential contribution to the OCB pattern interpretation [1] . Minor modifications to this scheme have been suggested ("Appendix").
The B2010 revised McDonald criteria^for MS diagnosis downplayed the diagnostic role of CSF testing, considered as supportive criterion for the diagnosis of primary-progressive MS only [10] . The criterion entails equivalence between CSF OCBs and abnormal IgG Index values, although IgG Index is less sensitive than OCBs for the intrathecal IgG synthesis detection, and at risk of false positive results in the presence of moderate/severe blood-CSF barrier damage [11] . The substantial exclusion of CSF analysis from MS diagnostic criteria has generated conflicting opinions (reviewed in [12] ). Notably, however, in patients with clinically isolated syndrome (CIS), CSF OCBs help define the risk of MS conversion with 91% sensitivity and 94% specificity [13] , with greater accuracy vs the criterion of dissemination in space on brain MRI (70 vs 58%) and improvement of global diagnostic accuracy [14] . Most importantly, the exclusion of alternative diagnosis, which requires CSF analysis, is also fundamental in CIS patients [15] and in general in patients with suspected CNS inflammatory diseases.
On the prognostic side, the revived association between absence of CSF OCB and benign MS prognosis [16] , has not been confirmed [17] . Moreover, some studies suggested that CSF OCBs of the IgM isotype associate with (a) aggressive MS forms [18] , (b) better responses to immunotherapies [19] , (c) lower risks of developing progressive multifocal leukoencephalopathy in patients on natalizumab [20] , and (d) higher probability of reaching EDSS scores of 3.0/4.0 10 years after onset [21] . The data are waiting for further confirmation and wider consensus before IgM OCB test enters routine clinico-laboratory practice [22] .
Neuromyelitis optica spectrum disorders
CSF is less sensitive than serum for the detection of AQP4-IgG [23] . Testing CSF samples is restricted to seronegative NMOSD patients comorbid for other autoimmune diseases, as these systemic diseases possibly associate with circulating autoantibodies that can interfere with anti-AQP-4 antibody detection [24] .
Creutzfeldt-Jacob disease
Western blot for CSF protein 14.3.3 determination is the reference test for the diagnosis of Creutzfeldt-Jacob disease [25] . Tau protein ELISA, which allows quantitative measurements, has high specificity and specificity (>90%) [26] , and could complement or replace the semiquantitative Western blot technique for protein 14.3.3 determination.
Alzheimer disease
A consensus paper by the BAlzheimer's Biomarkers Standardization Initiative^on one hand insisted on the need for standardization of biomarkers in AD and, on the other hand, recommended the routine practice of measuring the CSF concentrations of protein tau, hyperphosphorylated protein tau, and amyloid beta in patients with early onset dementia, prodrome of the disease, and atypical forms of AD [27] . Today, a good level of standardization has been reached thanks also to international quality control schemes. The typical modifications of the three biomarkers allow the diagnosis of AD in the initial phases, whereas normal values exclude the disease [27] . Regrettably, how an early diagnosis of AD may be relevant in prognostic and therapeutic terms is still rather unclear.
Amyotrophic lateral sclerosis
CSF neurofilaments are increasingly emerging as important biomarkers of axonal damage. Their determination is useful for the differential diagnosis of motor neuron diseases, and therefore, they should be included in the diagnostic workup of the disease [28] .
Inflammatory neuropathies
Increased values of CSF total proteins or albulmin quotient with normal CSF cell counts (albumino-cytologic dissociation) are often found in patients with GuillainBarré syndrome [29] or chronic inflammatory demyelinating polyradiculoneuropathy, in which they are considered one of the supportive criteria for the diagnosis [30] . Antigen-specific antibody index: OD CSF /OD serum ratio >1.5-2.0 indicates antigen-specific antibody intrathecal synthesis (the cutoff takes into account imprecision in total IgG and antigen-specific IgG measurements). 2.3.5.5 Immuno-affinity capillary blotting can be used for detecting antigen-specific OCBs [42] . It is labor-intensive, requires large amounts of viral proteins/peptides/lysates, and results of limited usefulness in routine practice. (human eyes are better in contrast discrimination), should be performed by two experienced operators. Particular attention should be paid to artifactual bands produced by the lack pH gradient homogeneity, due to regional weakness in conductivity within the gel; OCB-negative controls allow the recognition of such bands. 2.5.2 Adopt the following pattern classification: [1] i) Type 1, diffuse polyclonal IgG distribution in both CSF and serum (absence of intrathecal IgG synthesis, normal pattern). Reference values from published data can be adopted for both adult and pediatric patients. In adults with age >60 years, the physiological decrease of the CSF flow causes increases in albumin quotient (AQ) values, which can be thus non-indicative of blood-CSF barrier damage. For a more precise definition of the AQ upper reference limit, the formula 'AQ = age/25 + 8' has been proposed [48] . 
